Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
4.140
+0.060 (1.47%)
Sep 14, 2026, 2:15 PM EDT - Market open
Ironwood Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 684 | 548 | 709 | 1,786 | 1,901 | 1,908 | |
Market Cap Growth | 266.22% | -22.67% | -60.31% | -6.02% | -0.40% | 4.64% |
Enterprise Value | 1,002 | 1,006 | 1,236 | 2,414 | 1,742 | 1,804 |
Last Close Price | 4.08 | 3.37 | 4.43 | 11.44 | 12.39 | 11.66 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 5.27 | 22.83 | 805.60 | - | 10.86 | 3.61 |
Forward PE | 3.31 | 7.84 | 13.42 | 14.14 | 11.24 | 8.43 |
PS Ratio | 1.76 | 1.85 | 2.02 | 4.03 | 4.63 | 4.61 |
PB Ratio | - | -2.09 | -2.35 | -5.16 | 2.91 | 3.15 |
P/TBV Ratio | - | - | - | - | 2.91 | 3.15 |
P/FCF Ratio | 3.69 | 4.32 | 6.86 | 9.75 | 6.95 | 7.29 |
P/OCF Ratio | 3.69 | 4.32 | 6.85 | 9.74 | 6.94 | 7.29 |
PEG Ratio | - | 1.04 | 1.04 | 1.41 | 2.25 | 1.21 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.57 | 3.40 | 3.52 | 5.45 | 4.24 | 4.36 |
EV/EBITDA Ratio | 4.21 | 8.33 | 12.56 | 12.23 | 6.92 | 7.72 |
EV/EBIT Ratio | 4.24 | 8.46 | 12.82 | 12.33 | 6.96 | 7.77 |
EV/FCF Ratio | 5.40 | 7.92 | 11.95 | 13.18 | 6.37 | 6.90 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | -2.45 | -2.28 | -1.99 | -2.07 | 0.64 | 0.79 |
Debt / EBITDA Ratio | 1.65 | 4.83 | 5.85 | 3.56 | 1.63 | 2.01 |
Debt / FCF Ratio | 2.14 | 4.71 | 5.80 | 3.91 | 1.52 | 1.82 |
Net Debt / Equity Ratio | -1.96 | -1.46 | -1.70 | -1.80 | -0.37 | -0.24 |
Net Debt / EBITDA Ratio | 1.33 | 3.16 | 5.19 | 3.16 | -0.95 | -0.62 |
Net Debt / FCF Ratio | 1.71 | 3.01 | 4.94 | 3.40 | -0.88 | -0.55 |
Asset Turnover | 1.24 | 0.79 | 0.86 | 0.56 | 0.37 | 0.49 |
Quick Ratio | 5.84 | 1.08 | 4.39 | 0.80 | 30.23 | 4.54 |
Current Ratio | 6.06 | 1.13 | 4.70 | 0.85 | 30.58 | 4.61 |
Return on Equity (ROE) | - | - | - | -674.04% | 27.83% | 158.09% |
Return on Assets (ROA) | 47.02% | 19.88% | 14.65% | 15.58% | 14.05% | 17.21% |
Return on Invested Capital (ROIC) | 65.68% | 17.48% | 0.51% | 64.52% | 39.75% | 75.47% |
Return on Capital Employed (ROCE) | 93.70% | 76.90% | 30.90% | 100.40% | 23.30% | 24.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 18.98% | 4.38% | 0.12% | -56.11% | 9.21% | 27.69% |
FCF Yield | 27.12% | 23.17% | 14.59% | 10.25% | 14.40% | 13.71% |
Buyback Yield / Dilution | -3.27% | -1.81% | -2.99% | 16.57% | -13.32% | -2.34% |